The Use of Artificial Intelligence in the Management of Intracranial Aneurysms

The use of artificial intelligence (AI) has potential benefits in the management of intracranial aneurysms. Early detection of intracranial aneurysms is critical due to their high risk of complications such as rupture, vasospasm, and ischemia with highly impact on morbidity and mortality. The main findings suggest that AI can improve the accuracy of aneurysm detection, rupture risk prediction, and assist neurointervention in planning and performing procedures. This chapter discusses the potential for AI to improve patient care by enabling earlier diagnosis and timely treatment, reducing medical errors, costs, morbidity, and mortality. However, further validation of AI-based applications is necessary in a real-world clinical setting

MindReader : Unsupervised Classification of Electroencephalographic Data

Electroencephalogram (EEG) interpretation plays a critical role in the clinical assessment of neurological conditions, most notably epilepsy. However, EEG recordings are typically analyzed manually by highly specialized and heavily trained personnel. Moreover, the low rate of capturing abnormal events during the procedure makes interpretation time-consuming, resource-hungry, and overall an expensive process. Automatic detection offers the potential to improve the quality of patient care by shortening the time to diagnosis, managing big data and optimizing the allocation of human resources towards precision medicine. Here, we present MindReader, a novel unsupervised machine-learning method comprised of the interplay between an autoencoder network, a hidden Markov model (HMM), and a generative component: after dividing the signal into overlapping frames and performing a fast Fourier transform, MindReader trains an autoencoder neural network for dimensionality reduction and compact representation of different frequency patterns for each frame. Next, we processed the temporal patterns using a HMM, while a third and generative component hypothesized and characterized the different phases that were then fed back to the HMM. MindReader then automatically generates labels that the physician can interpret as pathological and non-pathological phases, thus effectively reducing the search space for trained personnel. We evaluated MindReader’s predictive performance on 686 recordings, encompassing more than 980 h from the publicly available Physionet database. Compared to manual annotations, MindReader identified 197 of 198 epileptic events (99.45%), and is, as such, a highly sensitive method, which is a prerequisite for clinical use